Q2 2025
Released Nov 7, 2024, after the close
10-Q filed Nov 7, 2024, 38 days after period end · 0001516513-24-000102
Q2 2025 · 10-Q
Revenue$136.83M$136.83M +20.4% vs Q2 2024+8.0% vs Q1 2025
Net Income$44.15M$44.15M +44.3% vs Q2 2024+6.7% vs Q1 2025
EPS Diluted$0.22$0.22 +46.7% vs Q2 2024+4.8% vs Q1 2025
Gross Profit$123,156,000+22.1%
Operating Income$53,142,000+57.3%
Operating Cash Flowderived$68,346,000+429.9%
Free Cash Flowderived$68,346,000+431.6%
Margins · derived
Gross margin90.0%+1.2 pt vs Q2 2024
Operating margin38.8%+9.1 pt vs Q2 2024
Net margin32.3%+5.3 pt vs Q2 2024
What the release said
The release
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $136.83M | $113.61M | $102.19M | $79.35M |
| Net Income | $44.15M | $30.60M | $26.30M | $36.09M |
| EPS Diluted | $0.22 | $0.15 | $0.12 | $0.17 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR